Research Summary
Age-related macular degeneration (AMD) drugs are medications used to treat the progressive and irreversible disease that affects the central part of the retina (macula) and can lead to vision loss. The main drugs used to treat AMD are anti-VEGF (vascular endothelial growth factor) medications. These drugs work by targeting and inhibiting the growth of abnormal blood vessels that can leak and cause damage to the macula. Some examples of anti-VEGF drugs used to treat AMD include Avastin, Lucentis, and Eylea. These drugs are usually administered via injection into the affected eye by a qualified healthcare professional. Other medications may also be prescribed to manage symptoms and prevent further vision loss.
According to DIResearch's in-depth investigation and research, the global Age Related Macular Degeneration Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Age Related Macular Degeneration Drug include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Age Related Macular Degeneration Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Age Related Macular Degeneration Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Age Related Macular Degeneration Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Age Related Macular Degeneration Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Age Related Macular Degeneration Drug Include:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Age Related Macular Degeneration Drug Product Segment Include:
Lucentis
Eylea
Avastin
Others
Age Related Macular Degeneration Drug Product Application Include:
Hospitals
Clinics
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Age Related Macular Degeneration Drug Industry PESTEL Analysis
Chapter 3: Global Age Related Macular Degeneration Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Age Related Macular Degeneration Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Age Related Macular Degeneration Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Age Related Macular Degeneration Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Age Related Macular Degeneration Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 Age Related Macular Degeneration Drug Product by Type 1.2.1 Global Age Related Macular Degeneration Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Lucentis 1.2.3 Eylea 1.2.4 Avastin 1.2.5 Others 1.3 Age Related Macular Degeneration Drug Product by Application 1.3.1 Global Age Related Macular Degeneration Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Age Related Macular Degeneration Drug Market Revenue Analysis (2019-2030) 1.5 Age Related Macular Degeneration Drug Market Development Status and Trends 1.5.1 Age Related Macular Degeneration Drug Industry Development Status Analysis 1.5.2 Age Related Macular Degeneration Drug Industry Development Trends Analysis 2 Age Related Macular Degeneration Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Age Related Macular Degeneration Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Age Related Macular Degeneration Drug Market Analysis by Regions 4.1 Age Related Macular Degeneration Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global Age Related Macular Degeneration Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Age Related Macular Degeneration Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2025-2030) 5 Global Age Related Macular Degeneration Drug Market Size by Type and Application 5.1 Global Age Related Macular Degeneration Drug Market Size by Type 5.2 Global Age Related Macular Degeneration Drug Market Size by Application 6 North America 6.1 North America Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Age Related Macular Degeneration Drug Market Size by Type 6.4 North America Age Related Macular Degeneration Drug Market Size by Application 6.5 North America Age Related Macular Degeneration Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Age Related Macular Degeneration Drug Market Size by Type 7.4 Europe Age Related Macular Degeneration Drug Market Size by Application 7.5 Europe Age Related Macular Degeneration Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Age Related Macular Degeneration Drug Market Size by Type 8.4 China Age Related Macular Degeneration Drug Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Age Related Macular Degeneration Drug Market Size by Type 9.4 APAC (excl. China) Age Related Macular Degeneration Drug Market Size by Application 9.5 APAC (excl. China) Age Related Macular Degeneration Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Age Related Macular Degeneration Drug Market Size by Type 10.4 Latin America Age Related Macular Degeneration Drug Market Size by Application 10.5 Latin America Age Related Macular Degeneration Drug Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Age Related Macular Degeneration Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Age Related Macular Degeneration Drug Market Size by Type 11.4 Middle East & Africa Age Related Macular Degeneration Drug Market Size by Application 11.5 Middle East & Africa Age Related Macular Degeneration Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Age Related Macular Degeneration Drug Market Revenue by Key Manufacturers (2020-2024) 12.2 Age Related Macular Degeneration Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 Age Related Macular Degeneration Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Regeneron Pharmaceuticals 13.1.1 Regeneron Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolio 13.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Bayer HealthCare 13.2.1 Bayer HealthCare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolio 13.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Novartis 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Novartis Age Related Macular Degeneration Drug Product Portfolio 13.3.3 Novartis Age Related Macular Degeneration Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Roche 13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Roche Age Related Macular Degeneration Drug Product Portfolio 13.4.3 Roche Age Related Macular Degeneration Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Kanghong Pharma 13.5.1 Kanghong Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolio 13.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Age Related Macular Degeneration Drug Industry Chain Analysis 14.2 Age Related Macular Degeneration Drug Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Age Related Macular Degeneration Drug Typical Downstream Customers 14.4 Age Related Macular Degeneration Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support